Summary
A new treatment planning program was developed for the heavy-ion therapy facility at GSI. In addition, a concise quality standard for treatment planning has been set up. It covers acceptance and constancy checks of all critical aspects in treatment planning. Dose verification measurements done during the commissioning phase show an overall good agreement with the treatment planning calculations.
Similar content being viewed by others
References
Haberer T, Becher W, Schardt D, et al. Magnetic scanning system for heavy ion therapy. Nucl Instr Meth 1993;A330:296–305.
Heeg P, Hartmann G, Jäkel O, et al. Quality assurance at the heavy ion therapy facility at GSI this proceedings.
Gademann G, Schlegel W, Bürkelbach J, et al. Dreidimensionale Bestrahlungsplanung — Untersuchungen zur klinischen Integration. Strahlenther Onkol 1993;169:159–67.
Bendl R. Virtuelle Therapiesimulation. In: Schlegel W, Bortfeld T, Stein J, Eds. Dreidimensionale Strahlentherapieplanung. Heidelberg: DKFZ. 1995:31–42.
Krämer M, Jäkel O. Therapy planning for heavy ion irradiation. In: Amaldi U, Larsson B, Lemoigne Y, Eds. Advances in Hadrontherapy. Amsterdam: Elsevier, 1997:351–8.
Haberer T. Entwicklung eines magnetischen Strahlführungssystems zur tumorkonformen Strahlentherapie mit schweren geladenen Teilchen. GSI-Report 1994; GSI-94-09.
Heinrich W, Wiegel B, Kraft G. ß, Zeff, dE/dx, range and restricted energy loss of heavy ions in the region 1<E<1000 MeV/u. GSI-Report 1991; GSI-91-30.
Jacob C. Reichweite-CT-Zahl-Beziehung von Phantommaterialien und Messungen mit einer neuentwickelten multisegmentierten lonisationskammer zur Dosisverifikation bei Schwerionenbestrahlung. Dissertation. Heidelberg, 1996.
Scholz M, Kraft G, Track structure and the calculation of biological effects of heavy charged particles. Adv Space Res 1996;18 1/2:5–14.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jäkel, O., Krämer, M., Hartmann, G.H. et al. Treatment planning for the heavy-ion facility at GSI. Strahlenther Onkol 175 (Suppl 2), 15–17 (1999). https://doi.org/10.1007/BF03038878
Issue Date:
DOI: https://doi.org/10.1007/BF03038878